Macrophages need two signals to begin healing process
In the immune system, macrophages act not only as soldiers responding to invading pathogens but also help rebuild the injured tissue once the infection is defeated. A new study by Yale School of Medicine researchers published in the journal Science show how they accomplish this seemingly unrelated task.
Natalia Szejko, MD, PhD Wins 2022 ESOC Young Research Investigator Award for Stroke Research
During the 2022 European Stroke Organisation Conference (ESOC) held from May 4-6, Natalia Szejko, MD, PhD a postdoctoral fellow in the Falcone Lab was awarded the ESOC Young Research Investigator Award in Stroke for her submitted abstract, “Epigenetic Age and Ischemic Stroke: Findings from the Health and Retirement Study.”
Philanthropist Nancy Davis Opens Up About Life with Multiple Sclerosis and Her Mission to Help Others
Philanthropist Nancy Davis tells her story of living with multiple sclerosis, from her diagnosis after a ski accident to how she eventually found the treatment plan that was right for her. Yale Neurology Chair David Hafler, MD also speaks about how far research into the autoimmune disease has come and what the most effective treatment strategies are.Source: People
Emily Gilmore, MD Joins the American Board of Clinical Neurophysiology
The American Board of Clinical Neurophysiology (ABCN) has invited associate professor Emily Gilmore, MD, to serve as board member, effective immediately. Dr. Gilmore will play a significant role in the ABCN examination development, including writing and editing questions.
Gianvito Masi, MD Named MGNet Scholar for Myasthenia Gravis Research
Gianvito Masi, MD, a neurologist in the lab of Kevin O’Connor, PhD, has been selected as a MGNet Scholar by the Myasthenia Gravis Rare Disease Network (MGNet), which is part of the National Institutes of Health’s Rare Diseases Clinical Research Network. The grant, “Investigating immune mechanisms underlying checkpoint inhibitor myasthenia gravis,” funds two years of research and will begin in June 2022.
Yale experts make strides in Multiple Sclerosis research
Yale School of Medicine researchers have furthered our understanding of the immune mechanisms of multiple sclerosis, discovered that B-cell depleting drugs reduce symptoms of inflammation in MS patients, and have made significant strides in earlier diagnoses.Source: Yale Daily News
The Migraine Breakthrough
Regarded as a game-changer in migraine treatment, researchers discovered that migraines are caused by activated fibers in the trigeminal nerve and the subsequent blood vessel dilation in the meninges. Monoclonal antibodies have been shown to block the chemical signal that causes this phenomenon, thereby greatly reducing the frequency and severity of migraine.Source: Connecticut Health I-Team
Bob Saget died of head injury after falling, autopsy says. Here’s what to know about head trauma.
Given that comedian Bob Saget died of a severe head injury, experts - including Yale School of Medicine Neurology Chair David Hafler, MD - gave expert advice on the exact nature of severe head trauma, risk factors for severe injury, tips for prevention, and actionable steps for seeking medical help.Source: The Washington Post
Julian Acosta, MD Wins 2022 Mordecai Y.T. Globus New Investigator Award for Stroke Research
Julian Acosta, MD, a postdoctoral fellow in the Falcone Lab in Yale's Department of Neurology, has won the Mordecai Y.T. Globus New Investigator Award for research which demonstrates how a poor combination of genomic risk factors correlates with more and larger silent strokes, even in people who do not display symptoms of neurological disease.
Introducing New Additions to the Outreach and Engagement Core of the Alzheimer's Disease Research Center
Carmen I. Carrión, Psy.D. has joined the ORE as an Associate Core Leader, joining Isis Burgos-Chapman, MD. Dr. Carrión is an Assistant Professor and a bilingual (Spanish) neuropsychologist in the department of Neurology.
Naila Makhani, MD, MPH, named Harry Weaver Neuroscience Scholar by the National Multiple Sclerosis Society
Naila Makhani, MD, MPH, has been named a Harry Weaver Neuroscience Scholar by the National Multiple Sclerosis (MS) Society, starting in July of 2022. The five-year early-career award is highly competitive and prestigious –a limited number of awards are given out by the National Multiple Sclerosis Society to highly qualified newly-independent researchers.
How Do I Explain My Myasthenia Gravis?
Neurological diseases like myasthenia gravis (MG) can be difficult to discuss with loved ones. A current MG patient and Yale's Richard Nowak, MD, director of the Yale Myasthenia Gravis clinic, provide some helpful tints to get the conversation started.Source: How Do I Explain My Myasthenia Gravis?
Julian Acosta, MD Wins 2022 Paul Dudley White International Scholar Award
Julian Acosta, MD has been selected for the American Heart Association's Paul Dudley White International Scholar Award for the abstract, "“Observed and Genomic Life’S Simple 7 Influence Brain Health-related Neuroimaging Traits in Persons Without Stroke Or Dementia,” on which which Dr. Acosta was primary author.
Women Under 35 Might Have Higher Risk of Ischemic Stroke Than Men: Here Are the Signs
Women younger than 35 are more likely to suffer and experience a more difficult recovery from ischemic stroke than men and older patients. Pregnancy and oral contraceptives might be contributing factor this phenomenon, according to Yale neurologist Hardik Amin, MD.Source: healthline
Nervous system consequences of COVID-19
It is uncertain whether unforeseen neurological consequences due to COVID-19 may develop years after initial infection. With millions of individuals affected, nervous system complications pose public health challenges for rehabilitation and recovery and for disruptions in the workforce due to loss of functional capacity. There is an urgent need to understand the pathophysiology of these disorders and develop disease-modifying therapies.Source: Science
Less Wattage, More Brain Power
Dennis Spencer, MD, the Harvey and Kate Cushing Professor Emeritus of Neurosurgery, and Hitten Zaveri, PhD, assistant professor of neurology are collaborating with researchers at the Yale School of Engineering and Applied Science to expand the treatment capabilities of Brain-Computer Interfaces for patients who suffer from conditions like epilepsy and paralysis.Source: Yale News/Yale Engineering Magazine)